Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: Recovery of connexin37 after 7-day simvastatin treatment

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 8, 2003, Pages 1391-1397

  Yeh, Hung I ^a   Lu, Chi Sheng ^a   Wu, Yih Jer ^a   Chen, Chih Chun ^a   Hong, Ray Ching ^a   Ko, Yu Shien ^b   Shiao, Ming Shi ^c   Severs, Nicholas J ^d   Tsai, Cheng Ho ^a,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Connexins; Endothelial cells; Gap junctions; Hyperlipidemia; Simvastatin

Indexed keywords

APOLIPOPROTEIN E; CONNEXIN 37; CONNEXIN 40; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FEMALE; GAP JUNCTION; HYPERLIPIDEMIA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME SERIES ANALYSIS;

ANIMALS; AORTA; CONNEXINS; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; GAP JUNCTIONS; HYPERLIPIDEMIAS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; SIMVASTATIN; TISSUE DISTRIBUTION;

EID: 0043235647     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000083508.21989.15     Document Type: Article

References (32)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Schwartz SM, deBlois D, O'Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
3. Menzoian JO, Haudenschild CC, Shipman JL, Nickerson CJ, Fuller RM, Chobanian AV. Correction of enhanced endothelial permeability by cessation of cholesterol feeding. J Vasc Surg. 1987;5:336-341.
4. Wu CC, Chang SW, Chen MS, Lee T. Early change of vascular permeability in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1995;15:529-533.
5. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002;22:225-230.
6. Lee WC, Chao WT, Yang VC. Effects of high-cholesterol diet on the interendothelial clefts and the associated junctional complexes in rat aorta. Atherosclerosis. 2001;155:307-312.
7. Van Rijen H, van Kempen MJ, Analbers LJ, Rook MB, van Ginneken AC, Gros D, Jongsma HJ. Gap junctions in human umbilical cord endothelial cells contain multiple connexins. Am J Physiol. 1997;272: C117-C130.
8. Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ. Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res. 1998;83:1248-1263.
9. Elfgang C, Eckert R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF, Willecke K. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol. 1995;129:805-817.
10. de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res. 2000;86:649-655.
11. Liao Y, Day KH, Damon DN, Duling BR. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA. 2001;98:9989-9994.
12. Goodenough DA, Simon AM, Paul, DL. Gap junctional intercellular communication in the mouse ovarian follicle. Novartis Found Symp. 1999;219:226-235; discussion 235-240.
13. Haefliger JA, Castillo E, Waeber G, Bergonzelli GE, Aubert JF, Sutter E, Nicod P, Waeber B, Meda P. Hypertension increases connexin43 in a tissue-specific manner. Circulation. 1997;95:1007-1014.
14. Haefliger JA, Meda P, Formenton A, Wiesel P, Zanchi A, Brunner HR, Nicod P, Hayoz D. Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase . Arterioscler Thromb Vasc Biol. 1999;19:1615-1622.
15. Yeh HI, Lupu F, Dupont E, Severs NJ. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol. 1997;17:3174-3184.
16. Yeh HI, Lai YJ, Chang HM, Ko YS, Severs NJ, Tsai CH. Multiple connexin expression in regenerating arterial endothelial gap junctions. Arrerioscler Thromb Vasc Biol. 2000;20:1753-1762.
17. Yeh HI, Chang HM, Lu WW, Lee YN, Ko YS, Severs NJ, Tsai CH. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem. 2000;48:1377-1389.
18. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001;21:1712-1719.
19. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497.
20. Blackburn JP, Peters NS, Yeh HI, Rothery S, Green CR, Severs NJ. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1219-1228.
21. Yeh HI, Lai YJ, Lee YN, Chen YJ, Chen YC, Chen CC, Chen SA, Lin CI, Tsai CH. Differential expression of connexin43 gap junctions in cardiomyocytes isolated from the canine thoracic veins. J Histochem Cytochem. 2003;51:259-266.
22. Malewicz B, Kumar VV, Johnson RG, Baumann WJ. Lipids in gap junction assembly and function. Lipids. 1990;25:419-427.
23. Chaytor AT, Marsh WL, Hutcheson IR, Griffith TM. Comparison of glycyrrhetinic acid isoforms and carbenoxolone as inhibitors of EDHF-type relaxations mediated via gap junctions. Endothelium. 2000;7:265-278.
24. Javid PJ, Watts SW, Webb RC. Inhibition of nitric oxide-induced vasodilation by gap junction inhibitors: a potential role for a cGMP-independent nitric oxide pathway. J Vasc Res. 1996;33:395-404.
25. Osborne JA, Siegman MJ, Sedar AW, Mooers SU, Lefer AM. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol. 1989;256:C591-C597.
26. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit, I: endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 1986;58:552-564.
27. Dell'Omo G, Bandinelli S, Penno G, Pedrinelli R, Mariani M. Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther. 2000;68:427-434.
28. Plum A, Hallas G, Magin T, Dombrowski F, Hagendorff A, Schumacher B, Wolpert C, Kim J, Lamers WH, Evert M, Meda P, Traub O, Willecke K. Unique and shared functions of different connexins in mice. Curr Biol. 2000;10:1083-1091.
29. Kruger O, Beny JL, Chabaud F, Traub O, Theis M, Brix K, Kirchhoff S, Willecke K. Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40. J Vasc Res. 2002;39:160-172.
30. van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. Tumour necrosis factor-α alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine. 1998;10:258-264.
31. Undas A, Brozek J, Musial J. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease. Clin Lab. 2002;48:287-296.
32. Zelvyte I, Dominaitiene R, Crisby M, Janciauskiene S. Modulation of inflammatory mediators and PPAR-γ and NF-κB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol Res. 2002;45:147-154.